The Bright Future of Gene Synthesis in the Coming Years

Gene synthesis is the process of artificially constructing genetic material and it has shown rapid growth recently.

As per a market research report, the gene synthesis market was valued at US$ 643.2 million in 2022. And it is expected to grow at an impressive 18.6% CAGR between 2023-2029.

The question here is - what does the future look like for gene synthesis?

Because of the high demand for personalised medicine, gene synthesis has found widespread applications in various areas like genetic engineering, biopharmaceuticals, vaccines, and more.

The falling costs of gene synthesis and sequencing over the last decade have also enabled many startups to enter this market. Investments are pouring in given the large addressable market size.

North America is leading in the adoption of gene synthesis technologies. Progress in fields like CRISPR gene editing and DNA data storage will further fuel the utilisation of artificial gene synthesis. The Asia Pacific market is expected to register the fastest growth in the coming years. As precision medicine and targeted drug development expand, pharmaceutical players will depend more on custom gene synthesis for biologics, DNA-based therapies or even antibody discovery.

However, there are ethical concerns regarding the misuse of artificially constructed viruses and pathogens. Strict biosafety regulations have been introduced for gene synthesis companies. Most firms have rigorous screening procedures in place to prevent hazardous sequences from being manufactured. And, not to forget, improper disposal of genetic waste is another worry. Proper oversight by regulatory authorities may enable further responsible acceleration of gene synthesis technologies.

So, in a nutshell, different factors like enhanced applications, declining costs, supportive regulations and growing investments are responsible for the bright picture for the future of producing synthetic DNA.

And, another fascinating fact is, custom gene synthesis can make drug discovery and development faster, more versatile and economical. With prudent safeguards in place, the promise this field holds for revolutionising healthcare, biofuels, agriculture as well as materials science.

Gene Synthesis Services at Bio Basic

Bio Basic is one of the largest professional and affordable gene synthesis companies globally. For over 15 years, we have silently synthesized millions of base pairs of genes for researchers worldwide. Bio Basic offers services for projects of any scale related to COVID-19, coronavirus variants, vaccines etc.

You can count on us for the affordability of gene synthesis services, expertise in complex long genes, confidentiality guarantee and progress reports for the project. We use advanced gene synthesis techniques beyond silicon-chip technology to reliably deliver large and tricky genes.

Choosing Bio Basic as a gene synthesis partner can help you reap significant benefits for research teams over the coming years.